IDEA Bio-Medical and BioTech a.s. Announce Agreement for Distribution in the CZR and E. Europe

 

Rehovot, Israel, and Prague, Czech Republic, September 3, 2013:

 

IDEA Bio-Medical and BioTech a.s. announced today an agreement for the distribution of IDEA Bio-Medical’s High Content Screening systems to research institutions and pharmaceutical companies in the Czech Republic, Slovak Republic, Hungary, Poland, Russian Federation, Romania, Bulgaria, Serbia, Slovenia, Turkey, Croatia, Montenegro, Estonia, Latvia, Lithuania, Moldova, Belarus, Ukraine, Macedonia, Kazakhstan.  .

 

This revolutionary, High-Definition, Automated Cell-Imaging system was designed to serve biomedical scientists that do not necessarily have expertise in microscopy systems.  The system operates at extremely high speeds of image acquisition, and generates very high quality images.  It's a wide field fluorescence and bright field microscope, that uses a patented, laser-based autofocus technology to very rapidly identify the image location and focus on it, using various magnifications.  The system is best suited for multi-well cell-based assays, run automatically or manually, but can also be used with other sample formats.  It's the optimal combination of image quality, speed, ease-of-use, and price. 

 

“If you've been following our recent news releases you realize we're on a roll.  Customers and distributors worldwide are convinced that Hermes is unique in that it serves their most common research needs, and yet is priced competitively.  Announcements will keep flowing, boasting sales to universities in Germany, and distribution agreements in Asia and elsewhere.  BioTech is a serious company, managed by a team of highly professional managers.  We look forward to a very fruitful collaboration with them,” said Ilan Friedman, Manager of Global Sales and Distribution Channels for IDEA Bio-Medical.


"We saw the unique value the WiScan High Content Screening systems provide and are excited to be the sole source of the product in the CEE and CIS markets. We’ve established ourselves as a leading provider of innovative solutions for the life science community, and the WiScan systems are an outstanding addition to our portfolio. There is truly nothing else like it out there," said Petr Kvapil, CEO of BioTech a.s.


WiScan® technology originated at Israel's Weizmann Institute of Science and at IDEA Bio-Medical’s parent company IDEA Machine Development, and was further developed by IDEA Bio-Medical as part of a commercialization agreement with YEDA – the Institute’s technology transfer arm.

 

About BioTech a.s.

 

Established in 1997 as the cooperative partner of research, clinical and industrial laboratories. BioTech is the European leader in the supply of instruments, reagents and consumables for the life science industry. Its main focus is the delivery, technical and application support of High Tech – State-of-the-Art instruments. Headquartered in the Heart of Europe - Prague, Czech Republic, with several branch offices, BioTech has created system of quick response to all possible customers’ needs. BioTech is ISO 9001 certified company.

what to do when your wife cheated on you link cheat on your wife website
vibramycin akne thepoliticalsword.com vibramycin tabletta